Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients

NCT01866904 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01866904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01866904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
June 19, 2013
Completion date
March 31, 2017
Enrollment
9,284 (actual)
Sites
309

Conditions

As the registry lists them; a condition with its own page is linked.

stable coronary artery disease (cad), myocardial infarction